minden pookies study guide 3

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/70

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 4:29 PM on 4/27/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

71 Terms

1
New cards

what is stem cell medicine

- a broad field of medicine that involved the use of stem cells or stem cell biology to treat disorders

- stem cell therapy

- activation of endogenous stem cells

2
New cards

stem cell therapy

- treating a patient by transplanting new stem cells into the body

3
New cards

activation of endogenous stem cells

- pharmacologically activating the patients' own adult stem cells to promote repair [type of regenerative medicine]

4
New cards

embryonic stem cells

- pluripotent: can be come almost any cell type

- advantage is high flexibility

- limitation is ethical

5
New cards

adult stem cells

- multipotent: limited differentiation

- advantages are lower ethical concerns

- also lower immune rejections, especially if autologous [from same patient]

- ex: hematopoietic stem cells [HSCs used for bone marrow transplants]

6
New cards

induced pluripotent stem cells [iPS]

- adult cells reprogrammed to a pluripotent state

- fewer ethical concerns and potential autologous therapy are advantages

- limitation is that the safety is still being studied

7
New cards

stem cell therapies that are already FDA approved and in routine clinical use

- hematopoietic stem cell transplantation [bone marrow, peripheral blood, and cord blood]

- used for leukemia, lymphoma, bone marrow failure syndromes [BMF], and certain genetic blood disorders

8
New cards

most cell therapies are still in

- clinical trials

- mostly use adult cells: HSCs and MSCs

- many target non-hematologic diseases

- many of these are in early clinical phases [phase 1 and 2], but some have advanced to later stages

9
New cards

non-hematologic diseases

- heart disease, diabetes, spinal cord injury, MS, epilepsy

10
New cards

major challenges of stem cell therapy

- insufficient regulation

- insufficient education

- technical challenges

- immune rejection

- side effects

11
New cards

insufficient regulation

- some treatments are not FDA-approved but still marketed

12
New cards

insufficient education

- patients may have unrealistic expectations

- literature about stem cells may be confusing

- it may be unclear what kinds of stem cells are used for research studies that patients see

13
New cards

difficulties with stem cells

- isolation

- growing the cells

- differentiate them properly

- get cells to integrate properly

14
New cards

undifferentiated cells may form

- tumors

15
New cards

immune rejection

- body may attack transplanted cells

- autologous therapy helps but it is not always possible

16
New cards

side effects

- risk of tumor formation and other unknown long-term effects

17
New cards

Diseases and applications of stem cell therapy

- blood disorders [most established use of stem cells]

- Parkinson's disease [PD, a neurodegenerative disease]

- Alzheimer's disease [AD, neurodegenerative disease]

- multiple sclerosis [MS]

- eye disorders

- skin damage/burns

- organ transplantation

- HIV

- heart failure

- osteoarthritis

18
New cards

Hematopoietic stem cell transplant [HSCT]

- an example of a blood disorder use for stem cell therapy

- destroy diseased bone marrow [cancer, leukemia, other blood disorders]

- transplant healthy stem cells

- cells rebuild blood + immune system

- the goal is to replace defective cells

- has been used for decades

19
New cards

What is Parkinson's disease?

- loss of dopamine-producing neurons

- tremors

- stiffness

- loss of movement control

20
New cards

what are the dopamine-producing neurons lost in Parkinson's

- A9 DA neurons

21
New cards

current treatments for PD

- Levodopa [L-Dopa] to replace dopamine

- Deep brain stimulation [DBS]

22
New cards

problem with levodopa

- helps for a while but does not stop neuron loss

23
New cards

stem cell goal in PD

- replace lost dopamine neurons by using stem cells

24
New cards

the new cell requirements for stem cell treatments for PD

- differentiate into the correct neuron type

- be delivered to the correct brain region

- be capable of long-term survival

- not form tumors

25
New cards

studies done in animals regarding stem cell use in PD step 1

- iPS cells were generated from fibroblasts from monkey models of PD

26
New cards

studies done in animals regarding stem cell use in PD step 2

- cells were differentiated into dopamine [DA] neurons

27
New cards

studies done in animals regarding stem cell use in PD step 3

- these neurons were transplanted back into the monkeys [autologous] or into other monkeys [allogenic]

28
New cards

studies done in animals regarding stem cell use in PD step 4

- autologous recipients showed improved movement and decreased signs of depression

29
New cards

Alzheimer's disease key features

- neurodegeneration affecting many brain areas

- protein buildup

- no cure

- stem cell therapy is still experimental

30
New cards

protein buildup in AD

- amyloid plaques

- Tau tangles

31
New cards

challenges with AD

- many cell types affected, unlike PD, where only one is affected

- need correct integration of cells in brain

- disease environment might damage new cells

32
New cards

MS key features

- immune system attacks myelin

- myelin is normally produced by oligodendrocytes and it insulates nerves

33
New cards

MS symptoms

- weakness, numbness, paralysis, cognitive issues

34
New cards

stem cell strategies for MS

- immune reset using HSCs [most promising]

- immunomodulation using MSCs

- remyelination

35
New cards

immune reset using HSCs goal

- this method uses autologous HSCT

- resets the immune system

36
New cards

immune reset using HSCs step 1

- harvest the patient's own HSCs

37
New cards

immune reset using HSCs step 2

- use high-dose chemotherapy to eliminate autoreactive immune cells that destroy the patient's own myelin

38
New cards

immune reset using HSCs step 3

- re-infuse the patient with their own stem cells

39
New cards

immune reset using HSCs step 4

- the immune system regenerates, and this somehow resets the immune system

40
New cards

immune reset using HSCs step 5

- DOES NOT repair myelin directly, but it reduces autoimmune attack and has been successful for some patients

41
New cards

immune reset using HSCs step 6

- this method is currently used in specialized centers for aggressive MS, but does not yet have specific FDA approval for MS

42
New cards

immunomodulation using MSCs

- MSCs are sourced from the patient's bone marrow or adipose tissue

- MSCs do not replace oligodendrocytes, but they have been shown to reduce the immune system and inhibit inflammation

- due to paracrine signaling, where the MSCs are thought to secrete signals that reduce T cell activation and production of inflammatory cytokines

- mixed results

- this method is still under investigation, but HSCT method so far seems to be more promising

43
New cards

Remyelination in MS

- use iPS cells derived from skin cells to replace damaged oligodendrocytes

- still in early preclinical stages

44
New cards

eye disorders

- macular degeneration [AMD]

- corneal damage

45
New cards

macular degeneration [AMD]

- damage to the retina [specifically, damage to the retinal pigment epithelial {RPE} cells]

46
New cards

stem cell approach AMD step 1

- use stem cells to replace RPE cells, inject these cells into the retina

47
New cards

stem cell approach AMD step 2

- these cells can come from iPS cells that are differentiated into RPE cells

48
New cards

stem cell approach AMD step 3

- protocols have been developed to differentiate ES cells into RPE cells for treatment of AMD

49
New cards

stem cell approach AMD step 4

- another study used patient-derived iPS cells that were differentiated into RPE and transplanted into the retina

50
New cards

stem cell approach AMD step 5

- these studies are in experimental stages or in clinical trials

51
New cards

corneal damage stem cell therapy

- a type of stem cell treatment under investigation for corneal damage involves the limbal system stem cells

- limbal stem cell therapy

52
New cards

limbus zone

- zone of tissue that surrounds the iris

53
New cards

limbal stem cell therapy step 1

- limbal stem cells can be isolated from the good eye or from a donor and added to the iris of the affected eye

54
New cards

limbal stem cell therapy step 2

- once transplanted, these cells may have the ability to regenerate the different layers that make up the cornea

55
New cards

limbal stem cell therapy step 3

- these types of studies are still in preclinical studies, in some cases, in clinical trials

56
New cards

some ideas for using stem cells to repair damaged/burned skin

- grow the patient's skin cells in the lab

- use them to create artificial skin

- iPS cells may be a better new option

- iPS cells can also be used to create artificial skin

- banking iPS cells may allow patients to have a strong genetic match

57
New cards

organ transplantation problem

- not enough donor organs

58
New cards

organ transplantation solution

- replace specific cells instead of the whole organ

- these stem cells would be differentiated before being used

- stem cells may repair tissues

- stem cells main also be genetically modified to correct genetic abnormalities

59
New cards

How does HIV work

- HIV is a virus that causes AIDs

- the HIV virus uses a combination a receptor [CD4] and coreceptor [CCR5] to enter the cell

60
New cards

can stem cells prevent AIDs?

- some patients who have HIV AIDs were unexpectedly cured after stem cell transplants that were done for reasons unrelated to their HIV AIDs

- this result was due to genetic mutation in CCR5 genes of donor cells, thereby blocking viral entry

- shows potential for future therapies

61
New cards

heart failure

- a condition where the heart cannot pump efficiently

62
New cards

DREAM-HF trial

- involved the use of MSCs

- used for heart failure

- MSCs from donors were injected into the heart muscle [myocardium] of patients

63
New cards

MSCs in DREAM-HF trial may

- reduce inflammation

- improve outcomes

- results were promising, but nor perfect so more testing needed

64
New cards

Osteoarthritis

- joint degradation

65
New cards

MSCs in osteoarthritis

- MSCs may be promising for treatment

- may develop into chondrocytes

- may reduce inflammation

- still in experimental stages/clinical trials

66
New cards

The type of neuron that is deficient in Parkinson's Disease is:

A. Dopamine neurons

B. Serotonin neuron

C. Limbus stem cells

D. MSC stem cells

E. A and D

A. Dopamine neurons

67
New cards

In the "Immune Reset" strategy for Multiple Sclerosis, clinicians use a patient's own __________ to regenerate the patient's immune system

hematopoietic stem cells [HSCs]

68
New cards

The cell type that produces myelin is:

A. oligodendrocytes

B. Dopamine neurons

C. Serotonin-producing neurons

D. MSCs

E. Muscle cells

A. oligodendrocytes

69
New cards

Which type of cells would be the most promising for the treatment of AMD?

A. Limbus cells

B. Retinal pigment epithelial cells

C. Mesenchymal cells

D. Keratinocytes

E. Both A and B

B. retinal pigment epithelial cells

70
New cards

Functional cures for HIV have been observed in patients who received stem cell transplants from donors possessing an inactivating mutation in the _________ gene

CCR5

71
New cards

________________ are cells that secrete components that make up cartilage and that are highly significant in osteoarthritis

- chondrocytes